| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |